1
|
Zhang Y, Xue Z, Hu S, Bai H, Wang J, Wang N. Chrysin Inhibits Pseudo-allergic Reaction by Suppressing Mitochondrial STAT3 Activation via MAS-Related GPR Family Member X2. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2021; 69:6569-6577. [PMID: 34100606 DOI: 10.1021/acs.jafc.1c02565] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Chrysin, one of the most pharmacologically active natural flavonoids, has been extracted from various plants. Mast cells are an important part of innate immunity-mediating anaphylaxis. Pseudo-allergic reactions are currently believed to be associated with the MAS-related GPR family member X2 (MrgX2). In this study, the anti-pseudo allergy effect of chrysin and its underlying mechanisms were studied in vitro and in vivo. Chrysin inhibited passive cutaneous anaphylaxis and systemic pseudo-allergy in vivo. LAD2 cell degranulation, calcium ion (Ca2+) influx, and adenosine 5'-triphosphate (ATP) content were significantly suppressed in a dose-dependent manner. Chrysin suppressed pseudo-allergic reactions through the PLC/IP3/Ca2+ and ERK/STAT3 serine 727 pathways downstream of MrgX2. Therefore, mitochondrial ATP, but not glycolysis, is vital for pseudo-allergic reactions mediated by MrgX2. This study provides new insights for the treatment of pseudo-allergy.
Collapse
Affiliation(s)
- Yongjing Zhang
- School of Pharmacy, Xi'an Jiaotong University, Xi'an 710049, China
| | - Zhuoyin Xue
- School of Pharmacy, Xi'an Jiaotong University, Xi'an 710049, China
| | - Shiling Hu
- School of Pharmacy, Xi'an Jiaotong University, Xi'an 710049, China
| | - Haoyun Bai
- School of Pharmacy, Xi'an Jiaotong University, Xi'an 710049, China
| | - Jue Wang
- School of Pharmacy, Xi'an Jiaotong University, Xi'an 710049, China
| | - Nan Wang
- School of Pharmacy, Xi'an Jiaotong University, Xi'an 710049, China
- Pazhou Lab, Guangzhou 510330, China
| |
Collapse
|
2
|
Zeng Z, Liu S, Luo W, Liang J, Peng A. Efficient Synthesis of Phosphorus/Nitrogen‐Containing Chrysin Derivatives via Classic Reactions. ChemistrySelect 2021. [DOI: 10.1002/slct.202004358] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Affiliation(s)
- Ziyi Zeng
- School of Chemistry Sun Yat-sen University 135 Xingangxi Lu Guangzhou China
| | - Shuang Liu
- School of Chemistry Sun Yat-sen University 135 Xingangxi Lu Guangzhou China
| | - Wenjun Luo
- School of Chemistry Sun Yat-sen University 135 Xingangxi Lu Guangzhou China
| | - Jiaxin Liang
- School of Chemistry Sun Yat-sen University 135 Xingangxi Lu Guangzhou China
| | - Ai‐Yun Peng
- School of Chemistry Sun Yat-sen University 135 Xingangxi Lu Guangzhou China
| |
Collapse
|
3
|
Patel RV, Mistry BM, Syed R, Parekh NM, Shin HS. Sulfonylpiperazines based on a flavone as antioxidant and cytotoxic agents. Arch Pharm (Weinheim) 2019; 352:e1900051. [PMID: 31339585 DOI: 10.1002/ardp.201900051] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2019] [Revised: 05/02/2019] [Accepted: 05/22/2019] [Indexed: 12/16/2022]
Abstract
Chrysin-based sulfonylpiperazines 7a-k were synthesized and investigated for their in vitro free radical scavenging potential as well as cytotoxic efficacies against selected cancer cell lines. Cytotoxicity of the new compounds toward noncancer cells was confirmed using the SRB assay against Madin-Darby Canine Kidney cells. Reaction of piperazine with different substituted benzenesulfonyl chlorides in triethylamine furnished sulfonylpiperazines (3a-k), which were then allowed to react with 7-(4-bromobutoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one (6) prepared reacting chrysin with 1,4-dibromobutane to give the final derivatives 7a-k. The results concluded that chrysin-sulfonylpiperazines exerted better antioxidant and anticancer efficacies than previously studied chrysin-piperazine precursors. For example, compounds 7h, 7j, and 7k with 4-OCF3 , 4-OCH3 , and 2,4-diOCH3 groups exhibited the best antioxidant potential against 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radicals. Moreover, halogenated analogues (7b, 7c, 7g, and 7h) demonstrated promising anticancer potential against SK-OV3, HeLa, and HT-29 cell lines, whereas those bearing a methoxy functional group (7j and 7k) had beneficial effects against the cell lines A-549 and HT-29. Thus, it can be confirmed from the bioassay results that the overall structural design as well as proper substitution is crucial to deliver the anticipated biological effects. Spectroscopic techniques such as FT-IR, 1 H NMR, 13 C NMR, mass and elemental analysis (CHN) were carried out to confirm the final structures.
Collapse
Affiliation(s)
- Rahul V Patel
- Department of Food Science and Biotechnology, Dongguk University, Seoul, Republic of Korea
| | - Bhupendra M Mistry
- Department of Food Science and Biotechnology, Dongguk University, Seoul, Republic of Korea
| | - Riyaz Syed
- Department of Chemistry, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad, India
| | - Nikhil M Parekh
- Department of Mathematics Science and Humanities, Shroff S. R. Rotary Institute of Chemical Technology, Valia, Gujarat, India
| | - Han-Seung Shin
- Department of Food Science and Biotechnology, Dongguk University, Seoul, Republic of Korea
| |
Collapse
|
4
|
Li Y, Zhang Q, He J, Yu W, Xiao J, Guo Y, Zhu X, Liu Y. Synthesis and biological evaluation of amino acid derivatives containing chrysin that induce apoptosis. Nat Prod Res 2019; 35:529-538. [PMID: 30897948 DOI: 10.1080/14786419.2019.1582043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
A series of chrysin amino acid derivatives were synthesized to evaluate for their antiproliferative activities against several cancer cell lines. Among the compounds tested, N-(2-((5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)octanoyl)-L-leucine methyl ester(5d) presented a good anti-proliferative activity in MDA-MB-231 and MCF-7 cells. Flow cytometry analysis showed that 5d induced apoptosis and prolonged cell cycle progression in MDA-MB-231 and MCF-7 cells. Western blot analysis showed that 5d significantly inhibited Akt phosphorylation (Ser473) in MDA-MB-231 and MCF-7 cells. In addition, 5d treatment markedly downregulated Bcl-2 and upregulated Bax in a dose-dependent manner. In vitro caspase activation assay showed that 5d induced apoptosis of MDA-MB-231 cells by enhancing caspase 3/7 activity. The regulatory effect of 5d on apoptosis of MDA-MB-231 and MCF-7 cells may be induced by mitochondrial apoptosis pathway. This study is of great significance for designing and developing more effective chrysin amino acid derivatives.
Collapse
Affiliation(s)
- Yang Li
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative innovation Center for Molecular Target new Drug Study, University of South China, Hengyang, China
| | - Qizhi Zhang
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative innovation Center for Molecular Target new Drug Study, University of South China, Hengyang, China
| | - Jun He
- Institute of Chemistry & Chemical Engineering, University of South China, Hengyang, China
| | - Wenmei Yu
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative innovation Center for Molecular Target new Drug Study, University of South China, Hengyang, China
| | - Jie Xiao
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative innovation Center for Molecular Target new Drug Study, University of South China, Hengyang, China
| | - Yu Guo
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative innovation Center for Molecular Target new Drug Study, University of South China, Hengyang, China
| | - Xiaoming Zhu
- Institute of Chemistry and Materials Science, Hengyang Normal University, Hengyang, China
| | - Yunmei Liu
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative innovation Center for Molecular Target new Drug Study, University of South China, Hengyang, China
| |
Collapse
|
5
|
Vitalone A, Allkanjari O. Epilobium spp: Pharmacology and Phytochemistry. Phytother Res 2018; 32:1229-1240. [PMID: 29575111 DOI: 10.1002/ptr.6072] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2017] [Revised: 02/02/2018] [Accepted: 02/09/2018] [Indexed: 12/19/2022]
Abstract
The Epilobium species and their extracts are very popular in folk medicine, for a wide range of applications. The purpose of this review is the analysis of the pharmacological properties of Epilobium spp, considering whether their effects (e.g., anti-inflammatory, antioxidant, antitumor, antimicrobial, analgesic, and antiandrogenic) could rationally justify the use of Epilobium as a treatment of numerous diseases. Even if numerous preclinical studies have been reported, randomized controlled clinical trials (for the evaluation of safety and efficacy), and eventually cost-effectiveness studies (to estimate the long-term cumulative costs), are still needed to confirm the usefulness of these medicinal plants in human diseases.
Collapse
Affiliation(s)
- Annabella Vitalone
- Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy
| | - Olta Allkanjari
- Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy
| |
Collapse
|
6
|
Wang Z, Deng X, Xiong S, Xiong R, Liu J, Zou L, Lei X, Cao X, Xie Z, Chen Y, Liu Y, Zheng X, Tang G. Design, synthesis and biological evaluation of chrysin benzimidazole derivatives as potential anticancer agents. Nat Prod Res 2017; 32:2900-2909. [PMID: 29063798 DOI: 10.1080/14786419.2017.1389940] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
A series of chrysin benzimidazole derivatives were synthesised and evaluated for their anticancer activity in the search for potential anticancer agents. Among them, compound 18 displayed the most potent anti-proliferative activity against MFC cells with IC50 values of 25.72 ± 3.95 μM. The flow cytometry results displayed that compound 18 induced apoptosis of MFC cells in a dose-dependent manner and caused the cell cycle to be arrested in the G0/G1 phase. Furthermore, the preliminary anticancer activity in vivo was also studied in tumour-bearing mice, and the compound 18 exerted good inhibition effect on tumour growth. These results suggested that compound 18 had good anticancer activity, which could be a potential anticancer agent after further optimisation and evaluation.
Collapse
Affiliation(s)
- Zhe Wang
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Xiangping Deng
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Shujuan Xiong
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Runde Xiong
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Juan Liu
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Liu Zou
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Xiaoyong Lei
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Xuan Cao
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Zhizhong Xie
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Yanming Chen
- b Mu Dan Jiang You Bo Pharmacertical Co. Ltd , Mudanjiang , China
| | - Yunmei Liu
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Xing Zheng
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| | - Guotao Tang
- a Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study , University of South China , Hengyang , China
| |
Collapse
|